| Bioactivity | Thalidezine is a novel activator of AMP-activated protein kinase (AMPK). Thalidezine can eliminate anti-apoptotic cancer cells through energy-mediated autophagy death. Thalidezine can be used to study apoptosis intervention [1]. |
| Name | Thalidezine |
| CAS | 18251-36-0 |
| Formula | C38H42N2O7 |
| Molar Mass | 638.75 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Law BYK, et al. Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death. Oncotarget. 2017 May 2;8(18):30077-30091. |
Thalidezine
CAS: 18251-36-0 F: C38H42N2O7 W: 638.75
Thalidezine is a novel activator of AMP-activated protein kinase (AMPK). Thalidezine can eliminate anti-apoptotic cancer
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.